Please use this identifier to cite or link to this item: https://doi.org/10.34133/2020/6925296
Title: Combating the coronavirus pandemic: early detection, medical treatment, and a concerted effort by the global community
Authors: Luo, Z. 
Ang, M.J.Y. 
Chan, S.Y.
Yi, Z. 
Goh, Y.Y.
Yan, S. 
Tao, J.
Liu, K.
Li, X.
Zhang, H.
Huang, W.
Liu, X. 
Issue Date: 16-Jun-2020
Publisher: American Association for the Advancement of Science
Citation: Luo, Z., Ang, M.J.Y., Chan, S.Y., Yi, Z., Goh, Y.Y., Yan, S., Tao, J., Liu, K., Li, X., Zhang, H., Huang, W., Liu, X. (2020-06-16). Combating the coronavirus pandemic: early detection, medical treatment, and a concerted effort by the global community. Research 2020 : 6925296. ScholarBank@NUS Repository. https://doi.org/10.34133/2020/6925296
Rights: Attribution 4.0 International
Abstract: The World Health Organization (WHO) has declared the outbreak of 2019 novel coronavirus, known as 2019-nCoV, a pandemic, as the coronavirus has now infected over 2.6 million people globally and caused more than 185, 000 fatalities as of April 23, 2020. Coronavirus disease 2019 (COVID-19) causes a respiratory illness with symptoms such as dry cough, fever, sudden loss of smell, and, in more severe cases, difficulty breathing. To date, there is no specific vaccine or treatment proven effective against this viral disease. Early and accurate diagnosis of COVID-19 is thus critical to curbing its spread and improving health outcomes. Reverse transcription-polymerase chain reaction (RT-PCR) is commonly used to detect the presence of COVID-19. Other techniques, such as recombinase polymerase amplification (RPA), loopmediated isothermal amplification (LAMP), clustered regularly interspaced short palindromic repeats (CRISPR), and microfluidics, have allowed better disease diagnosis. Here, as part of the effort to expand screening capacity, we review advances and challenges in the rapid detection of COVID-19 by targeting nucleic acids, antigens, or antibodies. We also summarize potential treatments and vaccines against COVID-19 and discuss ongoing clinical trials of interventions to reduce viral progression. Copyright © 2020 Zichao Luo et al. Exclusive Licensee Science and Technology Review Publishing House.
Source Title: Research
URI: https://scholarbank.nus.edu.sg/handle/10635/198583
ISSN: 26395274
DOI: 10.34133/2020/6925296
Rights: Attribution 4.0 International
Appears in Collections:Staff Publications
Elements

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_34133_2020_6925296.pdf3.21 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons